Public Policy Should Foster Alzheimer’s Treatment Availability: Comment on the Draft US Medicare Decision to Limit Payment for Aducanumab (Aduhelm(™)) to Patients Participating in Clinical Trials

Detalles Bibliográficos
Autor principal: Cummings, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427024/
https://www.ncbi.nlm.nih.gov/pubmed/35542996
http://dx.doi.org/10.14283/jpad.2022.25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427024/
https://www.ncbi.nlm.nih.gov/pubmed/35542996
http://dx.doi.org/10.14283/jpad.2022.25

Ejemplares similares